{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:16:18Z","timestamp":1790691378378,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.ymgme.2008.08.003","type":"journal-article","created":{"date-parts":[[2008,9,21]],"date-time":"2008-09-21T09:40:54Z","timestamp":1221990054000},"page":"133-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["In vivo delivery of human acid ceramidase via cord blood transplantation and direct injection of lentivirus as novel treatment approaches for Farber disease"],"prefix":"10.1016","volume":"95","author":[{"given":"Shobha","family":"Ramsubir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Nonaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Bedia","family":"Girb\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Carpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Levade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Medin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2008.08.003_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ymgme.2008.08.003_bib2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.ejhg.5201044","article-title":"Prevalence of lysosomal storage diseases in Portugal","volume":"12","author":"Pinto","year":"2004","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2008.08.003_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s004399900075","article-title":"The frequency of lysosomal storage diseases in The Netherlands","volume":"105","author":"Poorthuis","year":"1999","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2008.08.003_bib4","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3573","article-title":"Acid ceramidase deficiency: farber lipogranulomatosis","author":"Moser","year":"2001"},{"key":"10.1016\/j.ymgme.2008.08.003_bib5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/humu.5","article-title":"Molecular analysis of acid ceramidase deficiency in patients with Farber disease","volume":"17","author":"Bar","year":"2001","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2008.08.003_bib6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00000637-199710000-00011","article-title":"First case of surgical treatment of Farber\u2019s disease","volume":"39","author":"Haraoka","year":"1997","journal-title":"Ann. Plast. Surg."},{"key":"10.1016\/j.ymgme.2008.08.003_bib7","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/sj.bmt.1702489","article-title":"Bone marrow transplantation for infantile ceramidase deficiency (Farber disease)","volume":"26","author":"Yeager","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ymgme.2008.08.003_bib8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.pediatrneurol.2003.09.003","article-title":"The status of hematopoietic stem cell transplantation in lysosomal storage disease","volume":"29","author":"Malatack","year":"2003","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgme.2008.08.003_bib9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jpeds.2003.09.051","article-title":"Successful hematopoietic stem cell transplantation in Farber disease","volume":"144","author":"Vormoor","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2008.08.003_bib10","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1136\/ard.2005.048322","article-title":"Farber\u2019s disease without central nervous system involvement: bone-marrow transplantation provides a promising new approach","volume":"65","author":"Ehlert","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ymgme.2008.08.003_bib11","series-title":"Correction of Certain Genetic Diseases by Transplantation","first-page":"137","article-title":"Outcome of displacement bone marrow transplantation in Farber\u2019s disease: a report of a case","author":"Souillet","year":"1989"},{"key":"10.1016\/j.ymgme.2008.08.003_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/geno.1999.5940","article-title":"The human acid ceramidase gene (ASAH): structure, chromosomal location, mutation analysis, and expression","volume":"62","author":"Li","year":"1999","journal-title":"Genomics"},{"key":"10.1016\/j.ymgme.2008.08.003_bib13","doi-asserted-by":"crossref","first-page":"35352","DOI":"10.1074\/jbc.M103066200","article-title":"Human acid ceramidase: processing, glycosylation, and lysosomal targeting","volume":"276","author":"Ferlinz","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2008.08.003_bib14","doi-asserted-by":"crossref","first-page":"29948","DOI":"10.1074\/jbc.M303310200","article-title":"The reverse activity of human acid ceramidase","volume":"278","author":"Okino","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2008.08.003_bib15","doi-asserted-by":"crossref","first-page":"32978","DOI":"10.1074\/jbc.M301936200","article-title":"Purification and characterization of recombinant, human acid ceramidase. Catalytic reactions and interactions with acid sphingomyelinase","volume":"278","author":"He","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2008.08.003_bib16","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1089\/10430349950018003","article-title":"Retrovirus-mediated correction of the metabolic defect in cultured Farber disease cells","volume":"10","author":"Medin","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2008.08.003_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1380-2933(96)00059-0","article-title":"Viral vectors for gene therapy of hematopoietic cells","volume":"3","author":"Medin","year":"1997","journal-title":"Immunotechnology"},{"key":"10.1016\/j.ymgme.2008.08.003_bib18","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1089\/10430349950017293","article-title":"Circulating alpha-galactosidase A derived from transduced bone marrow cells: relevance for corrective gene transfer for Fabry disease","volume":"10","author":"Takenaka","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2008.08.003_bib19","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ymthe.2003.07.008","article-title":"Ex vivo gene therapy using bone marrow-derived cells: combined effects of intracerebral and intravenous transplantation in a mouse model of Niemann\u2013Pick disease","volume":"8","author":"Jin","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2008.08.003_bib20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.gt.3302839","article-title":"Efficient correction of Fabry mice and patient cells mediated by lentiviral transduction of hematopoietic stem\/progenitor cells","volume":"14","author":"Yoshimitsu","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgme.2008.08.003_bib21","doi-asserted-by":"crossref","first-page":"16909","DOI":"10.1073\/pnas.0407572101","article-title":"Bioluminescent imaging of a marking transgene and correction of Fabry mice by neonatal injection of recombinant lentiviral vectors","volume":"101","author":"Yoshimitsu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2008.08.003_bib22","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1073\/pnas.061020598","article-title":"Preselective gene therapy for Fabry disease","volume":"98","author":"Qin","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2008.08.003_bib23","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nbt0997-871","article-title":"Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo","volume":"15","author":"Zufferey","year":"1997","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymgme.2008.08.003_bib24","doi-asserted-by":"crossref","first-page":"7430","DOI":"10.1128\/jvi.69.12.7430-7436.1995","article-title":"High-titer packaging cells producing recombinant retroviruses resistant to human serum","volume":"69","author":"Cosset","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.ymgme.2008.08.003_bib25","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/S0022-2275(20)37457-5","article-title":"In situ assay of acid sphingomyelinase and ceramidase based on LDL-mediated lysosomal targeting of ceramide-labeled sphingomyelin","volume":"37","author":"Levade","year":"1996","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2008.08.003_bib26","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/0014-5793(93)80243-N","article-title":"The in situ degradation of ceramide, a potential lipid mediator, is not completely impaired in Farber disease","volume":"329","author":"Levade","year":"1993","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymgme.2008.08.003_bib27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0022-510X(95)00231-0","article-title":"Neurodegenerative course in ceramidase deficiency (Farber disease) correlates with the residual lysosomal ceramide turnover in cultured living patient cells","volume":"134","author":"Levade","year":"1995","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ymgme.2008.08.003_bib28","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0014-5793(98)00325-1","article-title":"Natural ceramide is unable to escape the lysosome, in contrast to a fluorescent analogue","volume":"426","author":"Chatelut","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymgme.2008.08.003_bib29","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1006\/abio.1999.4284","article-title":"A fluorescence-based high-performance liquid chromatographic assay to determine acid ceramidase activity","volume":"274","author":"He","year":"1999","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgme.2008.08.003_bib30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2008.08.003_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/abio.2001.5342","article-title":"Determination of ceramides and diglycerides by the diglyceride kinase assay","volume":"298","author":"Bielawska","year":"2001","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgme.2008.08.003_bib32","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1182\/blood-2005-03-1081","article-title":"Human short-term repopulating stem cells are efficiently detected following intrafemoral transplantation into NOD\/SCID recipients depleted of CD122+ cells","volume":"106","author":"McKenzie","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2008.08.003_bib33","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1084\/jem.178.3.1103","article-title":"Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice","volume":"178","author":"Tanaka","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymgme.2008.08.003_bib34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0009-8981(97)06527-3","article-title":"Model SV40-transformed fibroblast lines for metabolic studies of human prosaposin and acid ceramidase deficiencies","volume":"262","author":"Chatelut","year":"1997","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2008.08.003_bib35","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1182\/blood.V86.10.3745.bloodjournal86103745","article-title":"A functional comparison of CD34+ CD38\u2212 cells in cord blood and bone marrow","volume":"86","author":"Hao","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2008.08.003_bib36","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1182\/blood.V89.11.3919","article-title":"Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay","volume":"89","author":"Wang","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2008.08.003_bib37","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/stem.160166","article-title":"SCID mouse models of human stem cell engraftment","volume":"16","author":"Greiner","year":"1998","journal-title":"Stem Cells"},{"key":"10.1016\/j.ymgme.2008.08.003_bib38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.med.57.110104.115650","article-title":"Enzyme replacement for lysosomal diseases","volume":"57","author":"Brady","year":"2006","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ymgme.2008.08.003_bib39","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1006\/geno.2002.6686","article-title":"Insertional mutagenesis of the mouse acid ceramidase gene leads to early embryonic lethality in homozygotes and progressive lipid storage disease in heterozygotes","volume":"79","author":"Li","year":"2002","journal-title":"Genomics"},{"key":"10.1016\/j.ymgme.2008.08.003_bib40","first-page":"37","article-title":"Increased levels of spliced RNA account for augmented expression from the MFG retroviral vector in hematopoietic cells","volume":"3","author":"Krall","year":"1996","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgme.2008.08.003_bib41","doi-asserted-by":"crossref","first-page":"11382","DOI":"10.1073\/pnas.93.21.11382","article-title":"Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector","volume":"93","author":"Naldini","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2008.08.003_bib42","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/sj.mt.6300147","article-title":"Anti-CD25 targeted killing of bicistronically transduced cells: a novel safety mechanism against retroviral genotoxicity","volume":"15","author":"Ramsubir","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2008.08.003_bib43","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1749-6632.1999.tb08468.x","article-title":"Ex vivo expansion and genetic marking of primitive human and baboon hematopoietic cells","volume":"872","author":"Medin","year":"1999","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.ymgme.2008.08.003_bib44","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1523\/JNEUROSCI.23-12-05197.2003","article-title":"Bone marrow-derived cells that populate the adult mouse brain preserve their hematopoietic identity","volume":"23","author":"Vallieres","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymgme.2008.08.003_bib45","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0022-3476(84)81106-3","article-title":"Phenotypic variability in siblings with Farber disease","volume":"104","author":"Antonarakis","year":"1984","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2008.08.003_bib46","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s001090050150","article-title":"Immune-deficient SCID and NOD\/SCID mice models as functional assays for studying normal and malignant human hematopoiesis","volume":"75","author":"Lapidot","year":"1997","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ymgme.2008.08.003_bib47","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00062752-199704010-00008","article-title":"Immunologic tolerance","volume":"4","author":"Sarzotti","year":"1997","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.ymgme.2008.08.003_bib48","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/096368979500400409","article-title":"Microglia: the effector cell for reconstitution of the central nervous system following bone marrow transplantation for lysosomal and peroxisomal storage diseases","volume":"4","author":"Krivit","year":"1995","journal-title":"Cell Transplant."},{"key":"10.1016\/j.ymgme.2008.08.003_bib49","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.expneurol.2004.03.007","article-title":"VEGF disrupts the neonatal blood\u2013brain barrier and increases life span after non-ablative BMT in a murine model of congenital neurodegeneration caused by a lysosomal enzyme deficiency","volume":"188","author":"Young","year":"2004","journal-title":"Exp. Neurol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719208002059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719208002059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:18:04Z","timestamp":1761088684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719208002059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S1096719208002059"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2008.08.003","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo delivery of human acid ceramidase via cord blood transplantation and direct injection of lentivirus as novel treatment approaches for Farber disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2008.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}